Skip to main content
. Author manuscript; available in PMC: 2025 Jun 3.
Published in final edited form as: Cancer Biomark. 2024 Mar 7;42(1):CBM230340. doi: 10.3233/CBM-230340

Table 4.

Estimated proportion of predicted cases and controls in VU-SPN that truly met criteria, reported as median and 95% CI of bootstrapped samples

Estimated
True case True control Do not meet inclusion criteria

VU-SPN
 Predicted cases 0.979 [0.948, 1.00] 0.021 [0.00, 0.052] 0 [0, 0]
 Predicted controls 0.013 [0.006, 0.024] 0.987 [0.976, 0.994] 0.009 [0.002, 0.019]